Biotech Values

[miljenko]

<If Dr Reddy prevailed whats to stop them from securing an API contract with BASF ...which can produce the API ( see previous post ) and as far as I know are not bound by a supply agreement with AMRN>

That is fair assessment. Pure, +97% with CofA, is not that easy to make and API producers will have limited supply (when dose is 4g/day). Still, my view is that bigger AMRN fear is from epa/dha/dpa mix not pure apa itself.